Major Indexes

My Watchlist Items

      No Watchlist
Array ( [0] => stdClass Object ( [symbol] => CCXI [price] => 10.36 [beta] => 1.498069 [volAvg] => 2236214 [mktCap] => 722605824 [lastDiv] => 0 [range] => 9.55-70.29 [changes] => 0.47 [companyName] => ChemoCentryx Inc [currency] => USD [cik] => 0001340652 [isin] => US16383L1061 [cusip] => 16383L106 [exchange] => Nasdaq Global Select [exchangeShortName] => NASDAQ [industry] => Biotechnology [website] => http://www.chemocentryx.com/ [description] => ChemoCentryx, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of new medications for inflammatory disorders, autoimmune diseases, and cancer in the United States. Its lead drug candidate is Avacopan, an orally-administered complement inhibitor of the complement C5a receptor (C5aR), which is in Phase III development for the treatment of anti-neutrophil cytoplasmic auto-antibody-associated vasculitis; and Phase IIb clinical trial, the AURORA trial for the treatment of patients with moderate-to-severe hidradenitis suppurativa, as well as patients with complement 3 glomerulopathy. In addition, the company is developing CCX140, an inhibitor of the chemokine receptor known as CCR2, which has completed a Phase II clinical trial in diabetic nephropathy and is being developed for patients with focal segmental glomerulosclerosis; CCX507, a second generation CCR9 inhibitor, which has completed Phase I clinical trial; and CCX872, a potent and selective inhibitor of CCR2, which is in phase Ib clinical trial for the treatment of patients with stage 3 and 4 pancreatic cancer. ChemoCentryx, Inc. was founded in 1996 and is headquartered in Mountain View, California. [ceo] => Dr. Thomas Schall [sector] => Healthcare [country] => US [fullTimeEmployees] => 133 [phone] => 16502102900 [address] => 850 Maude Ave [city] => Mountain View [state] => CALIFORNIA [zip] => 94043 [dcfDiff] => [dcf] => 10.3817 [image] => https://financialmodelingprep.com/image-stock/CCXI.png [ipoDate] => 2012-02-08 [defaultImage] => [isEtf] => [isActivelyTrading] => 1 ) )
ChemoCentryx Inc (CCXI)
   10.36   0.47(+4.75%)
ChemoCentryx, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of new medications for inflammatory disorders, autoimmune diseases, and cancer in the United States. Its lead drug candidate is Avacopan, an orally-administered complement inhibitor of the complement C5a receptor (C5aR), which is in Phase III development for the treatment of anti-neutrophil cytoplasmic auto-antibody-associated vasculitis; and Phase IIb clinical trial, the AURORA trial for the treatment of patients with moderate-to-severe hidradenitis suppurativa, as well as patients with complement 3 glomerulopathy. In addition, the company is developing CCX140, an inhibitor of the chemokine receptor known as CCR2, which has completed a Phase II clinical trial in diabetic nephropathy and is being developed for patients with focal segmental glomerulosclerosis; CCX507, a second generation CCR9 inhibitor, which has completed Phase I clinical trial; and CCX872, a potent and selective inhibitor of CCR2, which is in phase Ib clinical trial for the treatment of patients with stage 3 and 4 pancreatic cancer. ChemoCentryx, Inc. was founded in 1996 and is headquartered in Mountain View, California.
TitleNamePayCurrency PayGenderYear BornTitle Since
Senior Vice President of Technical Operations Dr. Sangita Ghosh Ph.D. N/A USD N/A N/A
Senior Vice President & Head of Commercial Ms. Dalia R. Rayes N/A USD female N/A N/A
Senior Vice President of Clinical Devel. Dr. Catherine Lee Kelleher N/A USD N/A N/A
Senior Vice President of HR Ms. Kari E. Leetch N/A USD female N/A N/A
Executive Vice President & Chief Operating Officer Mr. Tausif Butt N/A USD male N/A N/A
Senior Vice President, Chief Bus. Officer & Treasurer Dr. Markus J. Cappel 563800 USD 1961 N/A
Executive Vice President, Chief Financial & Admin. Officer, Sec. and Director Ms. Susan M. Kanaya 696650 USD female 1963 N/A
Founder, Pres, Chief Executive Officer & Chairman Dr. Thomas J. Schall Ph.D. 968760 USD 1959 N/A
SymbolDateRatingRating Score Rating Details
CCXI 17 May, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
CCXI 14 May, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
CCXI 13 May, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
CCXI 12 May, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
CCXI 11 May, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
CCXI 10 May, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
CCXI 7 May, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
CCXI 6 May, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
CCXI 5 May, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
CCXI 4 May, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
CCXI 3 May, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
CCXI 30 April, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
CCXI 29 April, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
CCXI 28 April, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
CCXI 27 April, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
CCXI 26 April, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
CCXI 23 April, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
CCXI 22 April, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
CCXI 21 April, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
CCXI 20 April, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
CCXI 19 April, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
CCXI 16 April, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
CCXI 15 April, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
CCXI 14 April, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
CCXI 13 April, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
CCXI 12 April, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
CCXI 9 April, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
CCXI 8 April, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
CCXI 7 April, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
CCXI 6 April, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
CCXI 5 April, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
CCXI 1 April, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
CCXI 31 March, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
CCXI 30 March, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
CCXI 29 March, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
CCXI 26 March, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
CCXI 25 March, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
CCXI 24 March, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
CCXI 23 March, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
CCXI 22 March, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
CCXI 19 March, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
CCXI 18 March, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
CCXI 17 March, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
CCXI 16 March, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
CCXI 15 March, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
CCXI 12 March, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
CCXI 11 March, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
CCXI 10 March, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
CCXI 9 March, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
CCXI 8 March, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
CCXI 5 March, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
CCXI 4 March, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
CCXI 3 March, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
CCXI 2 March, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
CCXI 1 March, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
CCXI 26 February, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
CCXI 25 February, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
CCXI 24 February, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
CCXI 23 February, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
CCXI 22 February, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
CCXI 19 February, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
CCXI 18 February, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
CCXI 17 February, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
CCXI 5 February, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
CCXI 4 February, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
CCXI 3 February, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
CCXI 2 February, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
CCXI 1 February, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
CCXI 29 January, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
CCXI 28 January, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
CCXI 27 January, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
CCXI 26 January, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
CCXI 25 January, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
CCXI 22 January, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
CCXI 21 January, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
CCXI 20 January, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
CCXI 19 January, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
CCXI 15 January, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
CCXI 14 January, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
CCXI 13 January, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
CCXI 12 January, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
CCXI 11 January, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
CCXI 8 January, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
CCXI 7 January, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
CCXI 6 January, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
CCXI 5 January, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
CCXI 4 January, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
CCXI 31 December, 2020 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
CCXI 30 December, 2020 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
CCXI 29 December, 2020 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
CCXI 28 December, 2020 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
CCXI 24 December, 2020 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
CCXI 23 December, 2020 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
CCXI 22 December, 2020 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
CCXI 21 December, 2020 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
CCXI 18 December, 2020 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
CCXI 17 December, 2020 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
CCXI 16 December, 2020 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
CCXI 15 December, 2020 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
CCXI 14 December, 2020 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
HolderSharesDate ReportedChange
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM 79040 31 March, 2021 -211
Genesee Capital Advisors, LLC 36492 31 March, 2021 36492
JPMORGAN CHASE & CO 43404 31 March, 2021 43404
GLENMEDE TRUST CO NA 4806 31 March, 2021 59
Parallel Advisors, LLC 35 31 March, 2021 35
HARBOR INVESTMENT ADVISORY, LLC 1091 31 March, 2021 240
PANAGORA ASSET MANAGEMENT 22463 31 March, 2021 22463
PACER ADVISORS, INC. 1351 31 March, 2021 -908
Cutler Group LP 16080 31 March, 2021 16080
NISA INVESTMENT ADVISORS, LLC 2130 31 March, 2021 0
HARBOUR INVESTMENTS, INC. 0 31 March, 2021 0
Ensign Peak Advisors, Inc 37224 31 March, 2021 37224
WADDELL & REED FINANCIAL 70289 31 March, 2021 70289
QUADRANT CAPITAL GROUP LLC 3 31 March, 2021 0
Allianz Asset Management GmbH 31923 31 March, 2021 31923
Bank of New York Mellon Corp 211487 31 March, 2021 211487
Tarbox Family Office, Inc. 18 31 March, 2021 18
BANK OF MONTREAL /CAN/ 89554 31 March, 2021 -6019
DekaBank Deutsche Girozentrale 27100 31 March, 2021 27100
MEEDER ASSET MANAGEMENT 2292 31 March, 2021 2292
EMERALD ADVISERS, LLC 214672 31 March, 2021 -249289
EXANE DERIVATIVES 21005 31 March, 2021 991
GUGGENHEIM CAPITAL LLC 33966 31 March, 2021 -86
SIGNATUREFD, LLC 39 31 March, 2021 0
AlphaCrest Capital Management LLC 13000 31 March, 2021 13000
Daiwa Securities Group Inc. 137 31 March, 2021 137
CHARTWELL INVESTMENT PARTNERS, LLC 12430 31 March, 2021 -667
VICTORY CAPITAL MANAGEMENT 10392 31 March, 2021 10392
ENVESTNET ASSET MANAGEMENT 7674 31 March, 2021 7674
LOS ANGELES CAPITAL MANAGEMENT LLC 11400 31 March, 2021 -11485
EMC Capital Management 8110 31 March, 2021 8110
Arizona State Retirement System 14103 31 March, 2021 14103
Swiss National Bank 110700 31 March, 2021 110700
ALPS ADVISORS 125942 31 March, 2021 125942
SMITH ASSET MANAGEMENT GROUP LP 60 31 March, 2021 -1590
BNP PARIBAS ARBITRAGE, SA 122151 31 March, 2021 50353
AMERICAN INTERNATIONAL GROUP, INC. 28901 31 March, 2021 76
BARCLAYS PLC 95453 31 March, 2021 78280
HighTower Advisors, LLC 7042 31 March, 2021 7042
Russell Investments Group, Ltd. 27616 31 March, 2021 27616
LORD, ABBETT & CO. LLC 565911 31 March, 2021 565911
Banque Cantonale Vaudoise 2590 31 March, 2021 2590
Silvant Capital Management LLC 5699 31 March, 2021 5699
AMALGAMATED BANK 7060 31 March, 2021 7060
MUTUAL OF AMERICA CAPITAL MANAGEMENT LLC 52813 31 March, 2021 52813
DUALITY ADVISERS, LP 21043 31 March, 2021 -2625
UBS ASSET MANAGEMENT AMERICAS 59340 31 March, 2021 59340
Qube Research & Technologies Ltd 9918 31 March, 2021 9918
Pearl River Capital, LLC 4991 31 March, 2021 4991
MACQUARIE GROUP LTD 1283708 31 March, 2021 265553
Tekla Capital Management LLC 144447 31 March, 2021 144447
ASSETMARK, 35 31 March, 2021 35
FIRST MANHATTAN CO 300 31 March, 2021 0
FIRST MERCANTILE TRUST CO 2072 31 March, 2021 -243
Carmignac Gestion 53465 31 March, 2021 53465
EVENTIDE ASSET MANAGEMENT, LLC 560000 31 March, 2021 173000
BENJAMIN F. EDWARDS & COMPANY, INC. 104 31 March, 2021 104
NOMURA ASSET MANAGEMENT CO LTD 0 31 March, 2021 0
BANK OF AMERICA CORP /DE/ 148017 31 March, 2021 42093
Artal Group S.A. 750000 31 March, 2021 750000
Parkwood LLC 15558 31 March, 2021 15558
METROPOLITAN LIFE INSURANCE CO/NY 14 31 March, 2021 -14441
Steward Partners Investment Advisory, LLC 11530 31 March, 2021 11530
TRUIST FINANCIAL CORP 60827 31 March, 2021 -3567
WealthShield Partners, LLC 5676 31 March, 2021 5676
Knights of Columbus Asset Advisors LLC 27094 31 March, 2021 27094
PICTET ASSET MANAGEMENT LTD 1222487 31 March, 2021 -19546
Centiva Capital, LP 11446 31 March, 2021 11446
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 288600 31 March, 2021 33000
CHARLES SCHWAB INVESTMENT MANAGEMENT 374668 31 March, 2021 374668
Engineers Gate Manager LP 5200 31 March, 2021 5200
AMERIPRISE FINANCIAL 32577 31 March, 2021 32577
CAPTRUST FINANCIAL ADVISORS 3065 31 March, 2021 15
FEDERATED HERMES, INC. 34073 31 December, 2020 -12188
MACKAY SHIELDS LLC 33000 31 December, 2020 1700
AQR CAPITAL MANAGEMENT LLC 30547 31 December, 2020 -4444
BIRCHVIEW CAPITAL, LP 30000 31 December, 2020 0
MANUFACTURERS LIFE INSURANCE COMPANY, THE 29823 31 December, 2020 1265
GENESEE CAPITAL ADVISORS, LLC 28176 31 December, 2020 305
PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO 27655 31 December, 2020 0
RUSSELL INVESTMENTS GROUP, LTD. 27449 31 December, 2020 -634
KNIGHTS OF COLUMBUS ASSET ADVISORS LLC 27434 31 December, 2020 27434
DEKABANK DEUTSCHE GIROZENTRALE 27100 31 December, 2020 10600
PRINCIPAL FINANCIAL GROUP INC 26785 31 December, 2020 6942
KENNEDY CAPITAL MANAGEMENT, INC. 24562 31 December, 2020 -241
AVIVA PLC 23840 31 December, 2020 -19326
FRED ALGER MANAGEMENT, LLC 23235 31 December, 2020 -524
VOYA INVESTMENT MANAGEMENT LLC 21736 31 December, 2020 5176
PROSHARE ADVISORS LLC 21657 31 December, 2020 4478
METLIFE INVESTMENT MANAGEMENT, LLC 20952 31 December, 2020 0
QUANTITATIVE SYSTEMATIC STRATEGIES LLC 20815 31 December, 2020 1919
ATHANOR CAPITAL, LP 18465 31 December, 2020 8107
PARKWOOD LLC 17443 31 December, 2020 -41700
APERIO GROUP, LLC 17167 31 December, 2020 -1496
AMERIPRISE FINANCIAL INC 16427 31 December, 2020 1485
WINTON GROUP LTD 16301 31 December, 2020 -51420
STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM 16117 31 December, 2020 20
SEI INVESTMENTS CO 15434 31 December, 2020 -24756
STRS OHIO 15400 31 December, 2020 -2100
RAFFERTY ASSET MANAGEMENT, LLC 15355 31 December, 2020 -25920
HIGHVISTA STRATEGIES LLC 14475 31 December, 2020 5080
VICTORY CAPITAL MANAGEMENT INC 14121 31 December, 2020 649
ARIZONA STATE RETIREMENT SYSTEM 13986 31 December, 2020 922
CITIGROUP INC 12585 31 December, 2020 6283
HANDELSBANKEN FONDER AB 11600 31 December, 2020 4000
SUSQUEHANNA INTERNATIONAL GROUP, LLP 10715 31 December, 2020 -10972
EMC CAPITAL MANAGEMENT 8922 31 December, 2020 8922
HIGHTOWER ADVISORS, LLC 8841 31 December, 2020 41
CUBIST SYSTEMATIC STRATEGIES, LLC 8368 31 December, 2020 -3446
AMALGAMATED FINANCIAL CORP 7750 31 December, 2020 41
ZURCHER KANTONALBANK (ZURICH CANTONALBANK) 6560 31 December, 2020 2162
US BANCORP \DE\ 6542 31 December, 2020 3306
VIRGINIA RETIREMENT SYSTEM 6500 31 December, 2020 -2400
PUBLIC EMPLOYEES RETIREMENT ASSOCIATION OF COLORADO 6464 31 December, 2020 0
CHICAGO PARTNERS INVESTMENT GROUP LLC 6314 31 December, 2020 6314
ENGINEERS GATE MANAGER LP 6255 31 December, 2020 6255
AMUNDI PIONEER ASSET MANAGEMENT INC 5900 31 December, 2020 0
SILVANT CAPITAL MANAGEMENT LLC 5699 31 December, 2020 0
PEARL RIVER CAPITAL, LLC 5195 31 December, 2020 -118
CAMPBELL & CO INVESTMENT ADVISER LLC 5059 31 December, 2020 -3500
VIRTUS ETF ADVISERS LLC 4694 31 December, 2020 -38
HSBC HOLDINGS PLC 4505 31 December, 2020 4505
PROFUND ADVISORS LLC 4499 31 December, 2020 241
TEACHER RETIREMENT SYSTEM OF TEXAS 4390 31 December, 2020 4390
NOMURA HOLDINGS INC 4300 31 December, 2020 4300
WEALTH MANAGEMENT PARTNERS, LLC 4248 31 December, 2020 4248
AMERITAS INVESTMENT PARTNERS, INC. 4225 31 December, 2020 0
EQIS CAPITAL MANAGEMENT, INC. 4215 31 December, 2020 4215
STEWARD PARTNERS INVESTMENT ADVISORY, LLC 4167 31 December, 2020 1636
PRUDENTIAL FINANCIAL INC 4054 31 December, 2020 184
ADVISORS ASSET MANAGEMENT, INC. 4019 31 December, 2020 4019
SG3 MANAGEMENT, LLC 4000 31 December, 2020 -16000
RIVER WEALTH ADVISORS LLC 3800 31 December, 2020 0
ENVESTNET ASSET MANAGEMENT INC 3710 31 December, 2020 -613
BRIDGEFRONT CAPITAL, LLC 3709 31 December, 2020 3709
BRINKER CAPITAL INVESTMENTS, LLC 3628 31 December, 2020 3628
WEALTHSHIELD PARTNERS, LLC 3539 31 December, 2020 3539
SKANDINAVISKA ENSKILDA BANKEN AB (PUBL) 3400 31 December, 2020 1200
TWINBEECH CAPITAL LP 3395 31 December, 2020 3395
NEO IVY CAPITAL MANAGEMENT 3340 31 December, 2020 3273
GREAT WEST LIFE ASSURANCE CO /CAN/ 2837 31 December, 2020 0
O'SHAUGHNESSY ASSET MANAGEMENT, LLC 2727 31 December, 2020 -2810
BANQUE CANTONALE VAUDOISE 2642 31 December, 2020 -63
GRACE CAPITAL 2500 31 December, 2020 0
CUTLER GROUP LP 2062 31 December, 2020 -2251
PENSERRA CAPITAL MANAGEMENT LLC 1590 31 December, 2020 1000
TOWER RESEARCH CAPITAL LLC (TRC) 1341 31 December, 2020 -565
CWM, LLC 1071 31 December, 2020 71
ADVISOR GROUP HOLDINGS, INC. 855 31 December, 2020 766
QUANTBOT TECHNOLOGIES LP 500 31 December, 2020 500
ROYAL BANK OF CANADA 257 31 December, 2020 0
SOWELL FINANCIAL SERVICES LLC 185 31 December, 2020 0
DAIWA SECURITIES GROUP INC. 130 31 December, 2020 -259
VIRTUS ALTERNATIVE INVESTMENT ADVISERS, INC. 106 31 December, 2020 -103
BENJAMIN F. EDWARDS & COMPANY, INC. 104 31 December, 2020 104
PNC FINANCIAL SERVICES GROUP, INC. 42 31 December, 2020 28
IKARIAN CAPITAL, LLC 37 31 December, 2020 0
PARALLEL ADVISORS, LLC 35 31 December, 2020 0
GLASSMAN WEALTH SERVICES 32 31 December, 2020 0
ASSETMARK, INC 28 31 December, 2020 0
TARBOX FAMILY OFFICE, INC. 18 31 December, 2020 0
FINANCIAL GRAVITY COMPANIES, INC. 2 31 December, 2020 2
PANAGORA ASSET MANAGEMENT INC 25342 31 December, 2020 -26
FMR LLC 10381262 31 December, 2020 47389
WELLINGTON MANAGEMENT GROUP LLP 6148679 31 December, 2020 -554655
BLACKROCK INC. 4804697 31 December, 2020 332263
RA CAPITAL MANAGEMENT, L.P. 4776548 31 December, 2020 -50362
VANGUARD GROUP INC 4747470 31 December, 2020 167003
STATE STREET CORP 2012764 31 December, 2020 43529
CORMORANT ASSET MANAGEMENT, LP 1200000 31 December, 2020 -200000
WASATCH ADVISORS INC 1108804 31 December, 2020 31797
INVESCO LTD. 972683 31 December, 2020 272350
GEODE CAPITAL MANAGEMENT, LLC 794918 31 December, 2020 46809
LOOMIS SAYLES & CO L P 764173 31 December, 2020 286601
AVIDITY PARTNERS MANAGEMENT LP 757000 31 December, 2020 757000
GOLDMAN SACHS GROUP INC 739547 31 December, 2020 267725
D. E. SHAW & CO., INC. 697094 31 December, 2020 -76376
BAKER BROS. ADVISORS LP 656710 31 December, 2020 -243111
ARTAL GROUP S.A. 650000 31 December, 2020 650000
NORTHERN TRUST CORP 607896 31 December, 2020 -14497
POLAR CAPITAL HOLDINGS PLC 581194 31 December, 2020 581194
CITADEL ADVISORS LLC 573071 31 December, 2020 114846
MARSHALL WACE NORTH AMERICA L.P. 541390 31 December, 2020 -385292
TIMESSQUARE CAPITAL MANAGEMENT, LLC 533085 31 December, 2020 533085
LORD, ABBETT & CO. LLC 496764 31 December, 2020 -47632
NORGES BANK 464097 31 December, 2020 464097
PRICE T ROWE ASSOCIATES INC /MD/ 403128 31 December, 2020 121966
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 365604 31 December, 2020 1650
OPALEYE MANAGEMENT INC. 350000 31 December, 2020 -6000
DIMENSIONAL FUND ADVISORS LP 295882 31 December, 2020 -305656
WELLS FARGO & COMPANY/MN 258135 31 December, 2020 1606
RAYMOND JAMES & ASSOCIATES 228403 31 December, 2020 146524
OCTAGON CAPITAL ADVISORS LP 225076 31 December, 2020 225076
BANK OF NEW YORK MELLON CORP 218468 31 December, 2020 -3986
NUVEEN ASSET MANAGEMENT, LLC 218313 31 December, 2020 -279496
PEREGRINE CAPITAL MANAGEMENT LLC 205995 31 December, 2020 18751
TWO SIGMA ADVISERS, LP 202241 31 December, 2020 -77700
RAYMOND JAMES FINANCIAL SERVICES ADVISORS, INC. 200105 31 December, 2020 142812
INTEGRAL HEALTH ASSET MANAGEMENT, LLC 180000 31 December, 2020 -5000
TRI LOCUM PARTNERS LP 166077 31 December, 2020 166077
AMERICAN CENTURY COMPANIES INC 165656 31 December, 2020 -3300
TEKLA CAPITAL MANAGEMENT LLC 144447 31 December, 2020 0
UBS GROUP AG 130528 31 December, 2020 129931
ALPS ADVISORS INC 124523 31 December, 2020 36670
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM 115911 31 December, 2020 2789
SOFINNOVA INVESTMENTS, INC. 113213 31 December, 2020 31978
SWISS NATIONAL BANK 109000 31 December, 2020 10900
MAN GROUP PLC 108167 31 December, 2020 10036
DEUTSCHE BANK AG\ 104342 31 December, 2020 -6563
ALLIANCEBERNSTEIN L.P. 96741 31 December, 2020 -6300
SG AMERICAS SECURITIES, LLC 86565 31 December, 2020 42366
PUTNAM INVESTMENTS LLC 86213 31 December, 2020 13706
CREDIT SUISSE AG/ 83683 31 December, 2020 17970
TEACHERS RETIREMENT SYSTEM OF THE STATE OF KENTUCKY 83425 31 December, 2020 5445
WADDELL & REED FINANCIAL INC 80541 31 December, 2020 606
STATE OF WISCONSIN INVESTMENT BOARD 75100 31 December, 2020 -2400
WCM INVESTMENT MANAGEMENT, LLC 74059 31 December, 2020 -49
RHUMBLINE ADVISERS 66638 31 December, 2020 5025
RENAISSANCE TECHNOLOGIES LLC 66100 31 December, 2020 66100
UBS ASSET MANAGEMENT AMERICAS INC 58246 31 December, 2020 10224
MORGAN STANLEY 58058 31 December, 2020 26655
SILVERARC CAPITAL MANAGEMENT, LLC 53766 31 December, 2020 53766
CARMIGNAC GESTION 53465 31 December, 2020 -4931
PARAMETRIC PORTFOLIO ASSOCIATES LLC 52025 31 December, 2020 -29844
FIRST TRUST ADVISORS LP 51373 31 December, 2020 27696
ASSENAGON ASSET MANAGEMENT S.A. 49294 31 December, 2020 39186
JANE STREET GROUP, LLC 47136 31 December, 2020 -20927
NEW YORK STATE COMMON RETIREMENT FUND 44700 31 December, 2020 2100
JPMORGAN CHASE & CO 43689 31 December, 2020 25043
STATE OF NEW JERSEY COMMON PENSION FUND D 39865 31 December, 2020 -3458
AXA S.A. 39700 31 December, 2020 -7800
ENSIGN PEAK ADVISORS, INC 37224 31 December, 2020 0
ALLIANZ ASSET MANAGEMENT GMBH 36795 31 December, 2020 -71356
MOODY ALDRICH PARTNERS LLC 35160 31 December, 2020 14661
LEGAL & GENERAL GROUP PLC 34575 31 December, 2020 -61
POLAR CAPITAL LLP 808739 30 September, 2020 808739
NUMERIXS INVESTMENT TECHNOLOGIES INC 6506 30 June, 2020 6506
HolderSharesDate ReportedWeight Percent
Verition Fund Management LLC 14472 31 March, 2021 N/A
DIMENSIONAL FUND ADVISORS LP 137122 31 March, 2021 N/A
NEW YORK STATE COMMON RETIREMENT FUND 44700 31 March, 2021 N/A
PROFUND ADVISORS LLC 4499 9 February, 2021 N/A
EMERALD MUTUAL FUND ADVISERS TRUST 408828 29 January, 2021 N/A
Vanguard Total Stock Market Index Fund 1415680 31 August, 2020 0.01
SEI Institutional Managed - Tax-Managed Small/Mid Cap Fund 15000 31 August, 2020 0.1
SEI Institutional Investments - Small/Mid Cap Equity Fund 15200 31 August, 2020 0.08
iShares Morningstar Small-Cap Growth ETF 15678 31 August, 2020 0.32
SEI Institutional Managed - Small Cap Fund 15881 31 August, 2020 0.16
SSgA SPDR Russell 2000 US Small Cap UCITS ETF 16497 31 August, 2020 0.13
Vanguard Health Care Index Fund 119282 31 August, 2020 0.05
SEI Institutional Managed - Small Cap Growth Fund 17306 31 August, 2020 0.29
SEI Inst Inv Extended Market Index Fund 10600 31 August, 2020 0.04
iShares NASDAQ Biotechnology ETF 707081 31 August, 2020 0.39
iShares Russell 3000 ETF 11785 31 August, 2020 0.01
db x-trackers MSCI USA Index UCITS ETF 83232 31 August, 2020 0.15
ALPS Medical Breakthroughs ETF 80672 31 August, 2020 2.4
Fidelity MSCI Health Care Index ETF 17599 31 August, 2020 0.05
iShares NASDAQ US Biotechnology UCITS ETF 19790 31 August, 2020 0.39
iShares Core S&P Total U.S. Stock Market ETF 32300 31 August, 2020 0.01
Principal Healthcare Innovators Index ETF 13204 31 August, 2020 0.7
Direxion Daily S&P Biotech Bull 3X Shares 36463 31 August, 2020 0.46
iShares Russell 2000 Growth ETF 412269 31 August, 2020 0.24
CSIF (CH) III Equity World ex CH Small Cap Blue - Pension Fund 13351 31 August, 2020 0.04
iShares Russell 2000 ETF 956299 31 August, 2020 0.12
SPDR S&P Biotech ETF 852595 31 August, 2020 0.81
Lyxor MSCI World Information Technology TR UCITS ETF 13767 31 August, 2020 0.09
SEI US Small Companies Fund 14600 31 August, 2020 0.21
iShares Healthcare Innovation UCITS ETF 168233 31 August, 2020 0.66
Fidelity Growth Company Fund 3141060 31 July, 2020 0.32
Hartford MidCap Fund 2674880 31 July, 2020 1
Fidelity Select Biotechnology Portfolio 2062220 31 July, 2020 1.54
Fidelity Series Growth Company Fund 707639 31 July, 2020 0.31
Vanguard Extended Market Index Fund 689010 31 July, 2020 0.05
Vanguard Small-Cap Index Fund 624191 31 July, 2020 0.04
Fidelity Advisor Biotechnology Fund 544400 31 July, 2020 1.24
Delaware Small Cap Core Fund 510378 31 July, 2020 0.54
Vanguard Small-Cap Value Index Fund 377017 31 July, 2020 0.08
Hartford Capital Appreciation Fund 374865 31 July, 2020 0.32
Hartford MidCap HLS Fund, Inc. 360892 31 July, 2020 1
Hartford Capital Appreciation HLS Fund 320746 31 July, 2020 0.43
Fidelity Growth Company K6 Fund 275094 31 July, 2020 0.27
Fidelity OTC Portfolio 249006 31 July, 2020 0.06
Fidelity Extended Market Index Fund 228898 31 July, 2020 0.05
Emerald Growth Fund 220987 31 July, 2020 0.91
Loomis Sayles Small Cap Growth Fund 205606 31 July, 2020 0.53
Invesco DWA Healthcare Momentum ETF 178115 31 July, 2020 1.77
CREF Stock Account 167618 31 July, 2020 0.01
TIAA-CREF Quant Small-Cap Equity Fund 147003 31 July, 2020 0.33
Hartford SmallCap Growth HLS Fund 142995 31 July, 2020 0.62
Hartford SmallCap Growth Fund 108999 31 July, 2020 0.62
Hartford Small Company Fund 99653 31 July, 2020 0.81
Schwab Small-Cap Index Fund 95561 31 July, 2020 0.13
EQ/2000 Managed Volatility Portfolio 88306 31 July, 2020 0.12
Principal SmallCap Growth Fund I 85307 31 July, 2020 0.22
Fidelity Total Market Index Fund 73411 31 July, 2020 0.01
Allianz Biotechnologie 70330 31 July, 2020 1.02
Hartford Small Company HLS Fund, Inc. 65280 31 July, 2020 0.82
AST Small-Cap Growth Portfolio 64490 31 July, 2020 0.43
Vanguard Institutional Total Stock Market Index Fund 61785 31 July, 2020 0.01
Vanguard Russell 2000 Index Fund 55702 31 July, 2020 0.13
Oddo BHF US Mid Cap 49539 31 July, 2020 1
VALIC Mid Cap Strategic Growth Fund 45365 31 July, 2020 1
John Hancock VIT Small Cap Stock Trust 44896 31 July, 2020 0.78
AB Small Cap Core Portfolio 44380 31 July, 2020 0.27
Invesco NASDAQ Biotech UCITS ETF 43845 31 July, 2020 0.35
Vanguard Balanced Index Fund 43416 31 July, 2020 0.01
AST Small-Cap Growth Opportunities Portfolio 43370 31 July, 2020 0.34
MassMutual Select Small Cap Growth Equity Fund 40163 31 July, 2020 0.37
Vanguard Russell 2000 Growth Index Fund 39116 31 July, 2020 0.25
Fidelity Series Total Market Index Fund 36704 31 July, 2020 0.01
Invesco DWA SmallCap Momentum ETF 36395 31 July, 2020 0.88
TIAA-CREF Equity Index Fund 36243 31 July, 2020 0.01
Fidelity NASDAQ Composite Index Fund 35849 31 July, 2020 0.02
Alger Health Sciences Fund 30000 31 July, 2020 0.53
DWS Small Cap Growth Fund 29703 31 July, 2020 0.48
EQ/Small Company Index Portfolio 29200 31 July, 2020 0.15
Neuberger Berman Small Cap Growth Fund 27000 31 July, 2020 0.5
CREF Equity Index Account 26464 31 July, 2020 0.01
ATM Small Cap Managed Volatility Portfolio 24961 31 July, 2020 0.12
EQ/AB Small Cap Growth Portfolio 22200 31 July, 2020 0.06
MML Small Cap Growth Equity Fund 21899 31 July, 2020 0.64
VALIC Co I Small Cap Index Fund 21746 31 July, 2020 0.13
Xtrackers Russell 2000 UCITS ETF 21525 31 July, 2020 0.13
Transamerica T. Rowe Price Small Cap VP 19656 31 July, 2020 0.1
MainStay VP MacKay Small Cap Core Portfolio 18100 31 July, 2020 0.22
Schwab Total Stock Market Index Fund 17047 31 July, 2020 0.01
Vanguard Total World Stock Index Fund 15535 31 July, 2020 N/A
Pacific Select Small-Cap Index Portfolio 15351 31 July, 2020 0.13
Vanguard US Equity Index Fund 15017 31 July, 2020 0.01
Invesco Raymond James SB-1 Equity ETF 14207 31 July, 2020 0.67
Wells Fargo Fundamental Small Cap Growth Fund 13976 31 July, 2020 0.67
DWS Health and Wellness Fund 13857 31 July, 2020 0.24
Fidelity NASDAQ Composite Index Tracking Stock 12797 31 July, 2020 0.02
First Trust Small Cap Core Alphadex Fund 12755 31 July, 2020 0.17
MainStay MacKay Small Cap Core Fund 12600 31 July, 2020 0.22
John Hancock VIT - Small Cap Index 12108 31 July, 2020 0.13
ProShares Ultra Nasdaq Biotechnology 11066 31 July, 2020 0.35
AMG Managers Special Equity Fund 10059 31 July, 2020 0.26
Metropolitan Series-Loomis Sayles Small Cap Core Portfolio 10860 30 June, 2020 0.18
Northwestern Mutual Small Cap Growth Stock Portfolio 75829 30 June, 2020 0.69
AQR Small Cap Momentum Style Fund 12335 30 June, 2020 0.36
DekaLux-BioTech 16500 30 June, 2020 0.29
American Century Small Cap Growth Fund 122727 30 June, 2020 0.58
Wasatch Micro Cap Fund 126129 30 June, 2020 1.07
Vanguard Global Small-Cap Index Fund 15525 30 June, 2020 0.04
Russell Investments U.S. Small Cap Equity Fund 15494 30 June, 2020 0.07
Voya VP Russell Small Cap Index Port 15392 30 June, 2020 0.14
Federated Hermes MDT Small Cap Growth Fund 41648 30 June, 2020 0.31
Wasatch Ultra Growth Fund 258680 30 June, 2020 1.02
T. Rowe Price New Horizons Fund 134745 30 June, 2020 0.03
Vanguard Explorer Fund 468898 30 June, 2020 0.18
TIAA-CREF Small Cap Blend Index Fund 70884 30 June, 2020 0.14
T Rowe Price QM US Small-Cap Growth Equity Fund 171325 30 June, 2020 0.12
GuideStone Small Cap Equity Fund 14403 30 June, 2020 0.15
JNL/Mellon Capital Healthcare Sector Fund 29957 30 June, 2020 0.05
Wasatch Small Cap Growth Fund 314108 30 June, 2020 0.84
Metropolitan Series-Loomis Sayles Small Cap Growth Portfolio 27755 30 June, 2020 0.49
TD Health Sciences Fund 13841 30 June, 2020 0.08
Northwestern Mutual Mid Cap Growth Stock Portfolio 172122 30 June, 2020 0.93
Brighthouse Funds Trust II -T. Rowe Price Small Cap Growth Portfolio 25933 30 June, 2020 0.12
Northern Small Cap Index Fund 25443 30 June, 2020 0.14
Federated Hermes MDT Small Cap Core Fund 23483 30 June, 2020 0.19
Lord Abbett Series Fund - Developing Growth Portfolio 13232 30 June, 2020 0.93
BlackRock Advantage Small Cap Growth Fund 20542 30 June, 2020 0.19
iShares Russell 2000 Small-Cap Index Fund 75264 30 June, 2020 0.18
MetLife Russell 2000 Index Portfolio 19706 30 June, 2020 0.14
Lord Abbett Developing Growth Fund 354736 30 June, 2020 0.92
Putnam Small Cap Growth Fund 19400 30 June, 2020 0.21
KP Small Cap Equity Fund;Instl 17615 30 June, 2020 0.08
Espa Stock Biotec 68000 30 June, 2020 1.33
BlackRock Health Sciences Opportunities Portfolio 132000 31 May, 2020 0.09
BZ Fine Fund - Pharma 155000 31 May, 2020 9.95
UBS (CH) Inst Fd 2-Eq Global Small Cap Passive II 12550 31 May, 2020 0.04
BlackRock Health Sciences Trust II 109330 31 May, 2020 0.26
DFA U.S. Small Cap Portfolio 396580 30 April, 2020 0.16
Lord Abbett Micro Cap Growth Fund 46125 30 April, 2020 2
DFA U.S. Micro Cap Portfolio 205356 30 April, 2020 0.22
Fidelity Series Small Cap Opportunities Fund 319700 30 April, 2020 0.39
Goldman Sachs Small Cap Growth Insights Fund 19194 30 April, 2020 0.11
DFA Tax-Managed U.S. Small Cap Portfolio 74066 30 April, 2020 0.16
Fidelity Small Cap Index Fund 244015 30 April, 2020 0.13
BGF World Healthscience Fund 66844 30 April, 2020 0.05
DFA U.S. Core Equity 1 Portfolio 22140 30 April, 2020 0.01
DFA U.S. Core Equity 2 Portfolio 20878 30 April, 2020 N/A
Fidelity Stock Selector Small Cap Fund 59000 30 April, 2020 0.34
DFA T.A. U.S. Core Equity 2 Portfolio 19906 30 April, 2020 0.01
Pacific Select Developing Growth Portfolio 45326 31 March, 2020 0.95
Bridge Builder Small/Mid Cap Growth Fund 19294 31 March, 2020 0.02
Florida State Board Administration Fund 37626 31 March, 2020 N/A
Pictet-Biotech 511857 29 February, 2020 1.82
Protea Fund - Crawford Lake US Equities Fund 32522 31 December, 2019 2.34
BRJ BlackRock US Small Cap Equity BIG Data Strategy Fund (Non Hedged) 27385 30 September, 2019 0.11
BRJ BlackRock US Small Cap Equity BIG Data Strategy Fund (Hedged) 24014 30 September, 2019 0.11
Blackrock Active Stock Master Portfolio 10711 31 July, 2019 N/A
SymbolTransaction DateReporting CikSecurities Owned Company CikReporting NameAcquistion Or DispositionForm Type Securities TransactedSecurity NameLink
CCXI 2 March, 2021 0001648283 119857 0001340652 Edwards Thomas A. D 4 600 Common Stock View
CCXI 2 March, 2021 0001648283 120457 0001340652 Edwards Thomas A. D 4 500 Common Stock View
CCXI 1 March, 2021 0001733642 3232 0001340652 Kwan Pui San D 4 1817 Common Stock View
CCXI 1 March, 2021 0001733642 5049 0001340652 Kwan Pui San D 4 1530 Common Stock View
CCXI 1 March, 2021 0001733642 25834 0001340652 Kwan Pui San D 4 833 Stock Option (right to buy) View
CCXI 1 March, 2021 0001733642 6579 0001340652 Kwan Pui San A 4 833 Common Stock View
CCXI 1 March, 2021 0001733642 5746 0001340652 Kwan Pui San A 4 1125 Common Stock View
CCXI 1 March, 2021 0001733642 24750 0001340652 Kwan Pui San D 4 1125 Stock Option (right to buy) View
CCXI 1 March, 2021 0001733642 13897 0001340652 Kwan Pui San D 4 1389 Stock Option (right to buy) View
CCXI 1 March, 2021 0001733642 4621 0001340652 Kwan Pui San A 4 1389 Common Stock View
CCXI 1 March, 2021 0001422995 91243 0001340652 Cappel Markus J. A 4 5417 Common Stock View
CCXI 1 March, 2021 0001422995 18958 0001340652 Cappel Markus J. D 4 5417 Stock Option (right to buy) View
CCXI 1 March, 2021 0001422995 85826 0001340652 Cappel Markus J. D 4 5359 Common Stock View
CCXI 1 March, 2021 0001422995 91185 0001340652 Cappel Markus J. D 4 20680 Common Stock View
CCXI 1 March, 2021 0001422995 111865 0001340652 Cappel Markus J. D 4 7053 Common Stock View
CCXI 1 March, 2021 0001422995 118918 0001340652 Cappel Markus J. A 4 16008 Common Stock View
CCXI 1 March, 2021 0001422995 42292 0001340652 Cappel Markus J. D 4 16008 Stock Option (right to buy) View
CCXI 1 March, 2021 0001422995 102910 0001340652 Cappel Markus J. A 4 11667 Common Stock View
CCXI 1 March, 2021 0001422995 24792 0001340652 Cappel Markus J. D 4 11667 Stock Option (right to buy) View
CCXI 25 February, 2021 0001422995 19500 0001340652 Cappel Markus J. A 4 19500 Restricted Stock Units View
CCXI 25 February, 2021 0001226064 31400 0001340652 KANAYA SUSAN M A 4 31400 Restricted Stock Units View
CCXI 25 February, 2021 0001733642 16640 0001340652 Kwan Pui San A 4 16640 Stock Option (right to buy) View
CCXI 25 February, 2021 0001845266 87000 0001340652 Butt Tausif A 4 87000 Stock Option (right to buy) View
CCXI 25 February, 2021 0001422995 13500 0001340652 Cappel Markus J. A 4 13500 Stock Option (right to buy) View
CCXI 25 February, 2021 0001226064 21700 0001340652 KANAYA SUSAN M A 4 21700 Stock Option (right to buy) View
CCXI 25 February, 2021 0001423084 54600 0001340652 Schall Thomas J. A 4 54600 Stock Option (right to buy) View
CCXI 25 February, 2021 0001423084 79000 0001340652 Schall Thomas J. A 4 79000 Restricted Stock Units View
CCXI 9 February, 2021 0001422995 86526 0001340652 Cappel Markus J. A 4 700 Common Stock View
CCXI 9 February, 2021 0001422995 85826 0001340652 Cappel Markus J. D 4 700 Common Stock View
CCXI 9 February, 2021 0001422995 58300 0001340652 Cappel Markus J. D 4 700 Stock Option (right to buy) View
CCXI 9 February, 2021 0001648283 120957 0001340652 Edwards Thomas A. D 4 400 Common Stock View
CCXI 8 February, 2021 0001422995 85826 0001340652 Cappel Markus J. D 4 200 Common Stock View
CCXI 8 February, 2021 0001422995 86026 0001340652 Cappel Markus J. D 4 7220 Common Stock View
CCXI 8 February, 2021 0001422995 93246 0001340652 Cappel Markus J. A 4 7420 Common Stock View
CCXI 8 February, 2021 0001422995 59000 0001340652 Cappel Markus J. D 4 7420 Stock Option (right to buy) View
CCXI 5 February, 2021 0001422995 85826 0001340652 Cappel Markus J. D 4 805 Common Stock View
CCXI 5 February, 2021 0001422995 66420 0001340652 Cappel Markus J. D 4 805 Stock Option (right to buy) View
CCXI 5 February, 2021 0001422995 86631 0001340652 Cappel Markus J. A 4 805 Common Stock View
CCXI 4 February, 2021 0001733642 15286 0001340652 Kwan Pui San D 4 1389 Stock Option (right to buy) View
CCXI 4 February, 2021 0001733642 4621 0001340652 Kwan Pui San A 4 1389 Common Stock View
CCXI 4 February, 2021 0001733642 26667 0001340652 Kwan Pui San D 4 833 Stock Option (right to buy) View
CCXI 4 February, 2021 0001733642 6579 0001340652 Kwan Pui San A 4 833 Common Stock View
CCXI 4 February, 2021 0001733642 5746 0001340652 Kwan Pui San A 4 1125 Common Stock View
CCXI 4 February, 2021 0001422995 87226 0001340652 Cappel Markus J. A 4 1400 Common Stock View
CCXI 4 February, 2021 0001422995 67225 0001340652 Cappel Markus J. D 4 1400 Stock Option (right to buy) View
CCXI 4 February, 2021 0001422995 85826 0001340652 Cappel Markus J. D 4 1400 Common Stock View
CCXI 4 February, 2021 0001733642 25875 0001340652 Kwan Pui San D 4 1125 Stock Option (right to buy) View
CCXI 4 February, 2021 0001733642 3232 0001340652 Kwan Pui San D 4 3347 Common Stock View
CCXI 2 February, 2021 0001648283 121357 0001340652 Edwards Thomas A. D 4 7983 Common Stock View
CCXI 2 February, 2021 0001648283 129340 0001340652 Edwards Thomas A. D 4 12017 Common Stock View
CCXI 25 January, 2021 0001733642 7416 0001340652 Kwan Pui San A 4 834 Common Stock View
CCXI 25 January, 2021 0001733642 0 0001340652 Kwan Pui San D 4 834 Stock Option (right to buy) View
CCXI 25 January, 2021 0001733642 27500 0001340652 Kwan Pui San D 4 834 Stock Option (right to buy) View
CCXI 25 January, 2021 0001733642 4066 0001340652 Kwan Pui San A 4 834 Common Stock View
CCXI 25 January, 2021 0001733642 6582 0001340652 Kwan Pui San A 4 1125 Common Stock View
CCXI 25 January, 2021 0001733642 27000 0001340652 Kwan Pui San D 4 1125 Stock Option (right to buy) View
CCXI 25 January, 2021 0001733642 16675 0001340652 Kwan Pui San D 4 1391 Stock Option (right to buy) View
CCXI 25 January, 2021 0001733642 5457 0001340652 Kwan Pui San A 4 1391 Common Stock View
CCXI 25 January, 2021 0001733642 3232 0001340652 Kwan Pui San D 4 4184 Common Stock View
CCXI 25 January, 2021 0001422995 87201 0001340652 Cappel Markus J. A 4 1375 Common Stock View
CCXI 25 January, 2021 0001422995 85826 0001340652 Cappel Markus J. D 4 1375 Common Stock View
CCXI 25 January, 2021 0001422995 68625 0001340652 Cappel Markus J. D 4 1375 Stock Option (right to buy) View
CCXI 1 January, 2021 0001422995 82914 0001340652 Cappel Markus J. A 4 6667 Common Stock View
CCXI 1 January, 2021 0001422995 89581 0001340652 Cappel Markus J. A 4 6667 Common Stock View
CCXI 1 January, 2021 0001422995 0 0001340652 Cappel Markus J. D 4 6667 Restricted Stock Units View
CCXI 1 January, 2021 0001422995 6667 0001340652 Cappel Markus J. D 4 6667 Restricted Stock Units View
CCXI 1 January, 2021 0001422995 85826 0001340652 Cappel Markus J. D 4 11521 Common Stock View
CCXI 1 January, 2021 0001422995 97347 0001340652 Cappel Markus J. A 4 7766 Common Stock View
CCXI 1 January, 2021 0001422995 15534 0001340652 Cappel Markus J. D 4 7766 Restricted Stock Units View
CCXI 1 January, 2021 0001226064 118765 0001340652 KANAYA SUSAN M D 4 16498 Common Stock View
CCXI 1 January, 2021 0001226064 20667 0001340652 KANAYA SUSAN M D 4 10333 Restricted Stock Units View
CCXI 1 January, 2021 0001226064 10000 0001340652 KANAYA SUSAN M D 4 10000 Restricted Stock Units View
CCXI 1 January, 2021 0001226064 124930 0001340652 KANAYA SUSAN M A 4 10000 Common Stock View
CCXI 1 January, 2021 0001226064 114930 0001340652 KANAYA SUSAN M A 4 10000 Common Stock View
CCXI 1 January, 2021 0001226064 135263 0001340652 KANAYA SUSAN M A 4 10333 Common Stock View
CCXI 1 January, 2021 0001226064 0 0001340652 KANAYA SUSAN M D 4 10000 Restricted Stock Units View
CCXI 1 January, 2021 0001423084 2308880 0001340652 Schall Thomas J. D 4 47576 Common Stock View
CCXI 1 January, 2021 0001423084 2356456 0001340652 Schall Thomas J. A 4 34566 Common Stock View
CCXI 1 January, 2021 0001423084 69134 0001340652 Schall Thomas J. D 4 34566 Restricted Stock Units View
CCXI 1 January, 2021 0001423084 2321890 0001340652 Schall Thomas J. A 4 23333 Common Stock View
CCXI 1 January, 2021 0001423084 23334 0001340652 Schall Thomas J. D 4 23333 Restricted Stock Units View
CCXI 1 January, 2021 0001423084 0 0001340652 Schall Thomas J. D 4 30000 Restricted Stock Units View
CCXI 1 January, 2021 0001423084 2298557 0001340652 Schall Thomas J. A 4 30000 Common Stock View
CCXI 28 December, 2020 0001648283 141357 0001340652 Edwards Thomas A. D 4 10782 Common Stock View
CCXI 24 December, 2020 0001648283 152139 0001340652 Edwards Thomas A. D 4 14218 Common Stock View
CCXI 15 December, 2020 0001733642 3232 0001340652 Kwan Pui San D 4 42593 Common Stock View
CCXI 15 December, 2020 0001733642 28334 0001340652 Kwan Pui San D 4 11666 Stock Option (right to buy) View
CCXI 15 December, 2020 0001733642 45825 0001340652 Kwan Pui San A 4 11666 Common Stock View
CCXI 15 December, 2020 0001733642 34159 0001340652 Kwan Pui San A 4 16675 Common Stock View
CCXI 15 December, 2020 0001733642 18066 0001340652 Kwan Pui San D 4 16675 Stock Option (right to buy) View
CCXI 15 December, 2020 0001733642 28125 0001340652 Kwan Pui San D 4 10919 Stock Option (right to buy) View
CCXI 15 December, 2020 0001733642 17484 0001340652 Kwan Pui San A 4 10919 Common Stock View
CCXI 15 December, 2020 0001733642 834 0001340652 Kwan Pui San D 4 3333 Stock Option (right to buy) View
CCXI 15 December, 2020 0001733642 6565 0001340652 Kwan Pui San A 4 3333 Common Stock View
CCXI 15 December, 2020 0001423084 2286176 0001340652 Schall Thomas J. A 4 17619 Common Stock View
CCXI 15 December, 2020 0001423084 2268557 0001340652 Schall Thomas J. D 4 17619 Common Stock View
CCXI 15 December, 2020 0001423084 6988 0001340652 Schall Thomas J. D 4 17619 Stock Option (right to buy) View
CCXI 14 December, 2020 0001733642 0 0001340652 Kwan Pui San D 4 834 Stock Option (right to buy) View
CCXI 14 December, 2020 0001733642 4066 0001340652 Kwan Pui San A 4 834 Common Stock View
CCXI 14 December, 2020 0001733642 3232 0001340652 Kwan Pui San D 4 8957 Common Stock View
SymbolDatePeriodDownload XLSX File
CCXI 2021 FY Download XLSX File
CCXI 2020 FY Download XLSX File
CCXI 2019 FY Download XLSX File
CCXI 2018 FY Download XLSX File
CCXI 2017 FY Download XLSX File
CCXI 2016 FY Download XLSX File
CCXI 2015 FY Download XLSX File
CCXI 2014 FY Download XLSX File
CCXI 2013 FY Download XLSX File
CCXI 2012 FY Download XLSX File
CCXI 2021 Q2 Download XLSX File
CCXI 2021 Q1 Download XLSX File
CCXI 2020 Q4 Download XLSX File
CCXI 2020 Q3 Download XLSX File
CCXI 2020 Q2 Download XLSX File
CCXI 2020 Q1 Download XLSX File
CCXI 2019 Q1 Download XLSX File
CCXI 2019 Q4 Download XLSX File
CCXI 2019 Q3 Download XLSX File
CCXI 2019 Q2 Download XLSX File
CCXI 2018 Q2 Download XLSX File
CCXI 2018 Q4 Download XLSX File
CCXI 2018 Q3 Download XLSX File
CCXI 2018 Q1 Download XLSX File
CCXI 2017 Q1 Download XLSX File
CCXI 2017 Q2 Download XLSX File
CCXI 2017 Q4 Download XLSX File
CCXI 2017 Q3 Download XLSX File
CCXI 2016 Q4 Download XLSX File
CCXI 2016 Q1 Download XLSX File
CCXI 2016 Q2 Download XLSX File
CCXI 2016 Q3 Download XLSX File
CCXI 2015 Q1 Download XLSX File
CCXI 2015 Q4 Download XLSX File
CCXI 2015 Q3 Download XLSX File
CCXI 2015 Q2 Download XLSX File
CCXI 2014 Q2 Download XLSX File
CCXI 2014 Q4 Download XLSX File
CCXI 2014 Q3 Download XLSX File
CCXI 2014 Q1 Download XLSX File
CCXI 2013 Q2 Download XLSX File
CCXI 2013 Q4 Download XLSX File
CCXI 2013 Q3 Download XLSX File
CCXI 2013 Q1 Download XLSX File
CCXI 2012 Q2 Download XLSX File
CCXI 2012 Q4 Download XLSX File
CCXI 2012 Q3 Download XLSX File
CCXI 2012 Q1 Download XLSX File

Charts

Company Historical Earnings

DateSymbolEPSEPS EstimatedTimeRevenueRevenue Estimated
29 April, 2021 CCXI -0.43 -0.43 bmo 0 7930000
1 March, 2021 CCXI -0.43 -0.43 bmo 4358000 7990000
9 November, 2020 CCXI -0.35 -0.35 amc 5085000 0
10 August, 2020 CCXI 0.29 0.29 amc 49440000 57964137.931034
11 May, 2020 CCXI -0.35 -0.35 amc 6008000 5149714.2857143
10 March, 2020 CCXI -0.26 -0.26 amc 10047000 10047000
4 November, 2019 CCXI -0.22 -0.22 amc 10581000 13466727.272727
5 August, 2019 CCXI -0.26 -0.26 amc 7173000 6069461.5384615
6 May, 2019 CCXI -0.23 -0.23 amc 8327000 8689043.4782609
11 March, 2019 CCXI -0.21 -0.21 amc 9332000 11998285.714286
8 November, 2018 CCXI -0.22 -0.22 amc 8975000 9790909.0909091
9 August, 2018 CCXI -0.14 -0.14 amc 15022000 16095000
9 May, 2018 CCXI -0.19 -0.19 amc 9546000 11555684.210526
9 March, 2018 CCXI 0.8 0.8 bmo 56301000 14075250
7 November, 2017 CCXI -0.13 -0.13 amc 9029000 18058000
8 August, 2017 CCXI -0.19 -0.19 amc 8937000 7996263.1578947
10 May, 2017 CCXI -0.12 -0.12 amc 8230000 17145833.333333
14 March, 2017 CCXI -0.16 -0.16 amc 4889000 6722375
7 November, 2016 CCXI -0.15 -0.15 amc 4251000 2267200
8 August, 2016 CCXI -0.22 -0.22 amc 2795000 889318.18181818
10 May, 2016 CCXI -0.34 -0.34 bmo 4084000 3243176.4705882
14 March, 2016 CCXI -0.26 -0.26 amc 14506000 15621846.153846
9 November, 2015 CCXI -0.26 -0.26 amc 0 0
6 August, 2015 CCXI -0.28 -0.28 amc 0 0
6 May, 2015 CCXI -0.28 -0.28 amc 3689000 3689000
12 March, 2015 CCXI -0.28 -0.28 amc 3169000 3169000
5 November, 2014 CCXI -0.25 -0.25 amc 3510000 3931200
5 August, 2014 CCXI -0.28 -0.28 amc 3382000 3140428.5714286
8 May, 2014 CCXI -0.27 -0.27 amc 3523000 3131555.5555556
13 March, 2014 CCXI -0.22 -0.22 amc 725000 790909.09090909
7 November, 2013 CCXI -0.22 -0.22 amc 1522000 1798727.2727273
12 August, 2013 CCXI -0.23 -0.23 amc 3714000 4521391.3043478
13 May, 2013 CCXI -0.28 -0.28 amc 99000 91928.571428571
13 March, 2013 CCXI -0.28 -0.28 amc 2145000 2145000
13 November, 2012 CCXI -0.28 -0.28 bmo 1128000 886285.71428571
10 August, 2012 CCXI -0.3 -0.3 bmo 1128000 789600
10 May, 2012 CCXI -0.28 -0.28 bmo 1018000 763500

Company Profile

Company Name ChemoCentryx Inc
Symbol CCXI
Currency USD
Price 10.36
Exchange Name Nasdaq Global Select (NASDAQ)
Industry Biotechnology
CEO Dr. Thomas Schall
Sector Healthcare
Country US
Full Time Employees 133
Phone 16502102900
Address 850 Maude Ave
City Mountain View
State CALIFORNIA
Zip 94043
>